
|Articles|May 1, 2002
NSAIDs appear to lower PCa risk in Caucasian men
Rochester, MN-When Mayo Clinic researchers recently reported a link between nonsteroidal anti-inflammatory drugs (NSAIDs) and a reduced incidence of prostate cancer, it simply confirmed what many in the field already suspected.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
Integration of doublet and triplet therapy in metastatic prostate cancer
3
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
4
Sarah Azari, MD, on early sexual health education for women with bladder cancer
5






